Community Bank & Trust Waco Texas continued to hold its stake in UnitedHealth Group Inc. (NYSE:UNH) during the second quarter, Holdings Channel reports. The institutional investor owned 13,480 shares of the healthcare conglomerate’s stock at the end of the second quarter. Community Bank & Trust Waco Texas’ holdings in UnitedHealth Group were worth $1,903,000 as of its most recent filing with the SEC.
Other hedge funds have also bought and sold shares of the company. Bank of Montreal Can purchased a new position in shares of UnitedHealth Group during the second quarter worth $207,013,000. Dodge & Cox increased its position in shares of UnitedHealth Group by 9.6% in the first quarter. Dodge & Cox now owns 15,183,189 shares of the healthcare conglomerate’s stock worth $1,957,113,000 after buying an additional 1,324,136 shares during the last quarter. Prudential Financial Inc. increased its position in shares of UnitedHealth Group by 47.4% in the first quarter. Prudential Financial Inc. now owns 2,458,710 shares of the healthcare conglomerate’s stock worth $316,927,000 after buying an additional 790,220 shares during the last quarter. NN Investment Partners Holdings N.V. purchased a new position in shares of UnitedHealth Group during the first quarter worth $83,434,000. Finally, UBS Asset Management Americas Inc. increased its position in shares of UnitedHealth Group by 13.0% in the first quarter. UBS Asset Management Americas Inc. now owns 4,424,657 shares of the healthcare conglomerate’s stock worth $570,338,000 after buying an additional 508,995 shares during the last quarter. Institutional investors own 85.78% of the company’s stock.
UnitedHealth Group Inc. (NYSE:UNH) traded down 0.41% on Wednesday, hitting $137.60. The stock had a trading volume of 4,625,613 shares. The company has a 50-day moving average price of $138.11 and a 200-day moving average price of $136.27. UnitedHealth Group Inc. has a 1-year low of $107.51 and a 1-year high of $144.48. The stock has a market capitalization of $131.05 billion, a price-to-earnings ratio of 21.53 and a beta of 0.57.
UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, July 19th. The healthcare conglomerate reported $1.96 EPS for the quarter, topping the consensus estimate of $1.89 by $0.07. UnitedHealth Group had a return on equity of 19.08% and a net margin of 3.51%. The business earned $46.50 billion during the quarter, compared to the consensus estimate of $45.05 billion. Equities analysts predict that UnitedHealth Group Inc. will post $7.90 earnings per share for the current year.
The business also recently announced a quarterly dividend, which was paid on Tuesday, September 20th. Shareholders of record on Friday, September 9th were paid a $0.625 dividend. The ex-dividend date was Tuesday, September 6th. This represents a $2.50 annualized dividend and a yield of 1.82%. UnitedHealth Group’s dividend payout ratio is currently 39.12%.
A number of brokerages recently weighed in on UNH. Barclays PLC boosted their target price on shares of UnitedHealth Group from $151.00 to $164.00 and gave the stock an “overweight” rating in a report on Wednesday, July 20th. Credit Suisse Group AG restated a “buy” rating on shares of UnitedHealth Group in a report on Friday, June 10th. Leerink Swann restated a “buy” rating on shares of UnitedHealth Group in a report on Friday, June 10th. Royal Bank Of Canada boosted their target price on shares of UnitedHealth Group from $157.00 to $165.00 and gave the stock an “outperform” rating in a report on Wednesday, July 20th. Finally, Zacks Investment Research upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $160.00 target price on the stock in a report on Friday, July 22nd. One equities research analyst has rated the stock with a hold rating, twenty-four have assigned a buy rating and one has given a strong buy rating to the stock. The stock currently has a consensus rating of “Buy” and an average target price of $155.35.
In other UnitedHealth Group news, Director Richard T. Burke sold 40,000 shares of the firm’s stock in a transaction dated Wednesday, September 7th. The stock was sold at an average price of $135.31, for a total value of $5,412,400.00. Following the completion of the transaction, the director now owns 2,003,550 shares in the company, valued at approximately $271,100,350.50. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. 1.65% of the stock is owned by company insiders.
About UnitedHealth Group
UnitedHealth Group Incorporated is a diversified healthcare company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. The Company conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc. (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.